Switzerland · Series D startup
4 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 3 months ago
Funding summaryUpdated 26 Oct 2026
$124Mraised across 4 rounds since 2014, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Ysios Capital
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
EQT Life Sciences
VI PartnersHorizon 3 HealthcareL
EIC Accelerator
European Investment Bank
KurmaPartners
EQT life science
Ysios Capital
Invest-NLKurma Life Science PartnersMissing a round, or an investor who was in one? Tell us.
This firm lists Xeltis as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Xeltis's investors include EQT Life Sciences, VI Partners, Horizon 3 Healthcare, EIC Accelerator and European Investment Bank, and 6 more on record. Horizon 3 Healthcare led its latest round.
Xeltis has raised $124M across 4 rounds since 2014.
Xeltis's most recent round, $23M, was in Jul 2026, led by Horizon 3 Healthcare.
Xeltis's largest round on record is $53M (Series C), in Nov 2017.
Xeltis's first round on record, in Dec 2014, was backed by EQT life science, VI Partners and Kurma Life Science Partners.
Xeltis's latest named round is a Series D, in Aug 2023.
Xeltis is based in Switzerland.
Horizon 3 Healthcare led the funding round in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Switzerland · 
